Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-25

Clinical Trial Update: Effect of a 20% Reduction in Hyperbaric Bupivacaine Dose on High Spinal Block Incidence in Cesarean Delivery: A Risk-Stratified Randomized Controlled Trial. [Phase 4]

View source ↗

Summary

Phase 4 randomized trial assessing whether a 20% reduction in hyperbaric bupivacaine dose reduces high spinal block during cesarean delivery. The study is risk-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hyperbaric Bupivacaine (bupivacaine)

Snippet

Sponsor: Aswan University | Conditions: Cesarean Section Complications | Phase 4 | Status: NOT_YET_RECRUITING